tiprankstipranks

Gregory Critchfield Insider Profile

4 Followers
Gregory Critchfield, President Myriad Genetic Labs at Myriad Genetics, holds 807.27K shares in Sera Prognostics (Ticker: SERA), holds 129.55K shares in Myriad Genetics (Ticker: MYGN).
tipranks
Gregory Critchfield

Gregory Critchfield
Myriad Genetics (MYGN)
President Myriad Genetic Labs

Ranked #37,381 out of 97,997 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+23.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$10M
64.91%
35.09%
A breakdown of Gregory Critchfield's holdings

Insider Roles

Sera Prognostics
(SERA)
Director
Myriad Genetics
(MYGN)
President Myriad Genetic Labs
Roles that Gregory Critchfield holds in companies

Most Profitable Insider Trade

Stock:
Myriad Genetics
(MYGN)
Rating:Informative Sell
Date:Aug 28, 2009 - Aug 28, 2010
Return:+48.60%
The most profitable trade made by Gregory Critchfield

Gregory Critchfield's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Myriad Genetics
Aug 28, 2009
President Myriad Genetic Labs
Informative Sell
1.44M
$3.45M
Sera Prognostics
Jun 07, 2024
Director
Uninformative Buy
$6.38M
List of latest transactions for each holding click on a transaction to see Gregory Critchfield's performance on stock

Gregory Critchfield insider profile FAQ

What is the percentage of profitable transactions made by Gregory Critchfield?
The percentage of profitable transactions made by Gregory Critchfield is 50%.
    What is the average return per transaction made by Gregory Critchfield?
    The average return per transaction made by Gregory Critchfield is 23.70%.
      What stocks does Gregory Critchfield hold?
      Gregory Critchfield holds: MYGN, SERA stocks.
        What was Gregory Critchfield’s latest transaction?
        Gregory Critchfield latest transaction was an Uninformative Buy of ―.
          What was Gregory Critchfield's most profitable transaction?
          Gregory Critchfield’s most profitable transaction was an Informative Sell of MYGN stock on August 28, 2009. The return on the trade was 48.60%.
            What is Gregory Critchfield's role in Myriad Genetics?
            Gregory Critchfield's role in Myriad Genetics is President Myriad Genetic Labs.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.